Rapid response of a public health reference laboratory to the COVID-19 pandemic

Author:

Pinhata Juliana Maira Watanabe1,Brandao Angela Pires21,Leite Daniela1,Oliveira Rosangela Siqueira de1,Fukasawa Lucila Okuyama3,Gonçalves Maria Gisele3,Guerra Juliana Mariotti4,Araujo Leonardo José Tadeu de4,Mansueli Gina Ploeger1,Santos Lilian Beserra1,Borghesan Tarcilla Corrente1,Kimura Lidia Midori4,Takahashi Juliana Possatto Fernandes54,Garcia Juliana Alves4,Piza Ana Rita de Toledo4,Ferreira Camila Santos da Silva4,Polatto Ricardo1,Guerra Maria Luiza Leopoldo e Silva1,Fazioli Raquel dos Anjos2,Zanella Rosemeire Cobo1,Blanco Roberta Morozetti1ORCID,

Affiliation:

1. Instituto Adolfo Lutz, Centro de Bacteriologia, Av. Dr. Arnaldo, 351, 9º andar, 01246-000, São Paulo, SP, Brazil

2. Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, 21040-360, Rio de Janeiro, RJ, Brazil

3. Instituto Adolfo Lutz, Centro de Imunologia, Av. Dr. Arnaldo, 351, 11º andar, 01246-000, São Paulo, SP, Brazil

4. Instituto Adolfo Lutz, Centro de Patologia, Av. Dr. Arnaldo, 351, 7º andar, 01246-000, São Paulo, SP, Brazil

5. Universidade Federal do Mato Grosso do Sul, Faculdade de Medicina, Programa de Pós-graduação em Doenças Infecciosas e Parasitárias, Cidade Universitária, Caixa Postal 549, 79070-900, Campo Grande, MS, Brazil

Abstract

Introduction. Brazil was one of the most affected countries by the COVID-19 pandemic. Instituto Adolfo Lutz (IAL) is the reference laboratory for COVID-19 in São Paulo, the most populous state in Brazil. In April 2020, a secondary diagnostic pole named IAL-2 was created to enhance IAL’s capacity for COVID-19 diagnosis. Hypothesis/Gap Statement. Public health laboratories must be prepared to rapidly respond to emerging epidemics or pandemics. Aim. To describe the design of IAL-2 and correlate the results of RT-qPCR tests for COVID-19 with secondary data on suspected cases of SARS-CoV-2 infection in the São Paulo state. Methodology. This is a retrospective study based on the analysis of secondary data from patients suspected of infection by SARS-CoV-2 whose clinical samples were submitted to real-time PCR after reverse transcription (RT-qPCR) at IAL-2, between 1 April 2020 and 8 March 2022. RT-qPCR Ct results of the different kits used were also analysed. Results. IAL-2 was implemented in April 2020, just over a month after the detection of the first COVID-19 case in Brazil. The laboratory performed 304,250 RT-qPCR tests during the study period, of which 98 319 (32.3 %) were positive, 205827 (67.7 %) negative, and 104 (0.03 %) inconclusive for SARS-CoV-2. RT-qPCR Ct values≤30 for E/N genes of SARS-CoV-2 were presented by 79.7 % of all the samples included in the study. Conclusion. IAL was able to rapidly implement a new laboratory structure to support the processing of an enormous number of samples for diagnosis of COVID-19, outlining strategies to carry out work with quality, using different RT-qPCR protocols.

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3